bf/NASDAQ:KRYS_icon.jpeg

COM:KRYSTALBIO

Krystal Biotech, Inc.

  • Stock

USD

Last Close

182.29

22/11 21:00

Market Cap

5.52B

Beta: -

Volume Today

222.08K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
3.49M
-
average payables
117.50K
-
540.50K
360%
806K
49.12%
1.41M
75.50%
5.25M
271.26%
6.19M
17.86%
4.06M
34.46%
average receivables
21.02M
-
book value per share
0.07
-
9.23
13,553.79%
10.11
9.51%
12.76
26.26%
15.55
21.83%
26.74
72.00%
20.49
23.39%
0.03
99.86%
capex per share
-0.00
-
-0.04
1,016.61%
-0.20
409.02%
-0.40
101.81%
-0.79
96.32%
-3.08
289.67%
-2.08
32.49%
-0.00
99.98%
capex to depreciation
-7.50
-
-9.13
21.74%
-15.84
73.53%
-8.55
46.01%
-8.02
6.26%
-24.68
207.76%
-13.07
47.06%
-2.36
81.96%
capex to operating cash flow
0.01
-
0.05
371.83%
0.24
338.14%
0.34
44.57%
0.57
66.42%
1.43
150.50%
0.53
63.05%
0.13
74.78%
capex to revenue
-2.18
-
-0.23
-
cash per share
0.45
-
9.25
1,956.83%
9.98
7.83%
12.18
22.10%
14.44
18.54%
19.74
36.69%
14.87
24.64%
0.02
99.87%
days of inventory on hand
days payables outstanding
days sales outstanding
302.66
-
debt to assets
0.84
-
0.02
-
0.04
138.01%
0.01
65.51%
0.02
24.85%
0.00
88.74%
debt to equity
6.38
-
0.02
-
0.04
145.90%
0.01
65.80%
0.02
26.54%
0.00
88.93%
dividend yield
earnings yield
-0.03
-
-0.14
455.56%
-0.05
66.70%
-0.02
53.66%
-0.03
31.65%
-0.04
57.02%
-0.07
54.69%
0.00
100.00%
enterprise value
45.41M
-
6.80M
85.02%
129.13M
1,798.46%
696.35M
439.26%
870.51M
25.01%
1.22B
40.08%
1.87B
53.06%
3.44T
184,339.13%
enterprise value over ebitda
-39.80
-
-1.43
96.40%
-10.97
665.67%
-32.64
197.65%
-27.95
14.38%
-18.67
33.19%
-16.83
9.88%
-31.37K
186,344.43%
ev to operating cash flow
-34.64
-
-1.75
94.95%
-13.67
681.90%
-37.21
172.18%
-33.37
10.31%
-25.44
23.78%
-18.56
27.04%
-38.77K
208,774.13%
ev to sales
125.74
-
67.90K
-
free cash flow per share
-0.31
-
-0.76
146.61%
-1.04
36.30%
-1.58
51.49%
-2.18
37.94%
-5.24
140.47%
-6.02
14.99%
-0.00
99.94%
free cash flow yield
-0.03
-
-0.07
149.43%
-0.05
31.00%
-0.03
43.16%
-0.04
27.32%
-0.07
106.26%
-0.08
1.53%
-0.00
99.96%
graham net net
0.01
-
9.13
130,041.09%
9.72
6.42%
11.80
21.39%
13.44
13.93%
18.26
35.88%
13.45
26.33%
0.02
99.86%
graham number
0.64
-
17.52
2,638.59%
14.87
15.12%
18.57
24.88%
24.47
31.82%
43.43
77.44%
50.31
15.85%
0.02
99.97%
income quality
1.14
-
0.49
56.92%
0.87
76.60%
0.98
13.02%
0.81
17.29%
0.69
15.02%
0.72
4.27%
-8.12
1,230.63%
intangibles to total assets
0
-
0
0
0
0
0
0
0
interest coverage
-163.29
-
-1.52
99.07%
-11.60
665.41%
-45.76
-
-27.81
39.23%
interest debt per share
0.43
-
0.59
35.72%
0.09
84.39%
0.21
123.78%
0.61
199.58%
0.43
30.24%
0.56
29.51%
0.00
99.99%
inventory turnover
invested capital
6.38
-
0.02
-
0.04
145.90%
0.01
65.80%
0.02
26.54%
0.00
88.93%
market cap
45.49M
-
56.39M
23.97%
232.80M
312.82%
880.60M
278.27%
1.13B
28.01%
1.55B
37.74%
2.02B
30.06%
3.44T
170,386.14%
net current asset value
276K
-
49.27M
17,752.90%
109.76M
122.75%
189.77M
72.90%
256.30M
35.06%
409.55M
59.79%
347.56M
15.14%
548.20M
57.73%
net debt to ebitda
0.07
-
10.44
14,793.49%
8.80
15.69%
8.64
1.90%
8.24
4.57%
5.10
38.09%
1.38
72.97%
3.25
135.82%
net income per share
-0.27
-
-1.48
449.29%
-0.97
34.21%
-1.20
23.50%
-1.71
42.63%
-3.13
83.05%
-5.49
75.19%
0.00
100.01%
operating cash flow per share
-0.31
-
-0.73
136.66%
-0.84
16.18%
-1.18
39.59%
-1.39
17.97%
-2.16
55.56%
-3.95
82.67%
-0.00
99.92%
payables turnover
receivables turnover
1.21
-
research and ddevelopement to revenue
7.56
-
0.92
-
return on tangible assets
-0.53
-
-0.16
70.01%
-0.09
40.66%
-0.09
2.62%
-0.10
13.32%
-0.11
7.34%
-0.25
125.64%
0.01
105.33%
revenue per share
0.09
-
0.00
-
roe
-3.98
-
-0.16
95.98%
-0.10
39.93%
-0.09
2.18%
-0.11
17.07%
-0.12
6.42%
-0.27
128.69%
0.01
105.24%
roic
-0.54
-
-0.10
82.01%
-0.11
9.11%
-0.11
0.18%
-0.10
0.69%
-0.11
6.97%
-0.27
140.04%
-0.16
39.82%
sales general and administrative to revenue
4.05
-
shareholders equity per share
0.07
-
9.23
13,553.79%
10.11
9.51%
12.76
26.26%
15.55
21.83%
26.74
72.00%
20.49
23.39%
0.03
99.86%
stock based compensation to revenue
0.77
-
0.79
-
tangible asset value
289K
-
49.47M
17,019.03%
113.23M
128.86%
202.91M
79.21%
292.08M
43.94%
593.58M
103.22%
522.23M
12.02%
778.64M
49.10%
tangible book value per share
0.07
-
9.23
13,553.79%
10.11
9.51%
12.76
26.26%
15.55
21.83%
26.74
72.00%
20.49
23.39%
0.03
99.86%
working capital
2.13M
-
49.27M
2,217.69%
110.05M
123.35%
192.55M
74.96%
259.61M
34.82%
416.53M
60.45%
354.93M
14.79%
554.82M
56.32%

All numbers in USD (except ratios and percentages)